arrow
Y

Yasunori Masuike

University of Osaka
H指数:10
被引数:406

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Early tumor shrinkage during first-line immune checkpoint inhibitor–based chemotherapy is associated with progression-free survival in measurable unresectable gastric cancer

一线免疫检查点抑制剂为基础化疗期间早期肿瘤缩小与可测量不可切除胃癌的无进展生存期相关

2026-09-180
OAAI
Zolbetuximab-induced gastric mucosal injury and hypoalbuminemia: a mechanism-informed clinical analysis

佐立倍单抗诱导的胃黏膜损伤和低白蛋白血症:一项机制导向的临床分析

2026-07-200
PRE
Clinical Outcomes of First-Line Immune Checkpoint Inhibitor–Based Therapy for Postoperative Recurrence After Adjuvant Nivolumab in Esophageal Cancer

术后辅助纳武利尤单抗治疗后食管癌复发患者一线免疫检查点抑制剂为基础治疗的临床结局

2026-05-200
PRE
Correction: Risk Stratification of Postoperative Recurrence After Adjuvant Nivolumab for Resected Locally Advanced Esophageal Cancer: A Real-World Study

更正:辅助纳武利尤单抗治疗切除后局部晚期食管癌术后复发的风险分层:一项真实世界研究

2026-05-040
PRE
Learning curve for the abdominal procedure in total robot-assisted minimally invasive esophagectomy with simultaneous cervical approach: an initial experience

在同时采用颈部入路的全机器人辅助微创食管切除术中的腹部手术学习曲线:初步经验

2026-05-011
PRE
ASO Visual Abstract: Risk Stratification of Postoperative Recurrence After Adjuvant Nivolumab for Resected Locally Advanced Esophageal Cancer: A Real-World Study

ASO视觉摘要:辅助尼洛替尼治疗切除的局部晚期食管癌术后复发的风险分层:一项真实世界研究

2026-04-220
PRE
Risk Stratification of Postoperative Recurrence After Adjuvant Nivolumab for Resected Locally Advanced Esophageal Cancer: A Real-World Study

术后辅助纳武利尤单抗治疗局部晚期食管癌切除术后复发的风险分层:一项真实世界研究

2026-04-140
PRE
Zolbetuximab-based chemotherapy in CLDN18.2-positive gastric cancer: real-world tumor response and early albumin kinetics

Zolbetuximab联合化疗在CLDN18.2阳性胃癌中的应用:真实世界肿瘤反应及早期白蛋白动力学

2026-02-010
PRE
A single-center retrospective study of conversion surgery in stage IV gastric cancer: association with immune checkpoint inhibitor-based chemotherapy

单中心回顾性研究:IV期胃癌转化手术与基于免疫检查点抑制剂化疗的相关性

2026-01-011
PRE
Clinical outcomes of 23-mm circular stapled cervical anastomosis after esophagectomy
2025-11-010
PRE
Robotic esophageal reconstruction with a diagonal stapling technique: technical description and early outcomes from a single-center series

机器人食管重建术采用对角线吻合技术:技术描述和单中心系列研究的早期结果

2025-11-010
PRE
Postoperative chemotherapy after conversion surgery for clinical stage IV gastric cancer: a propensity score-matched analysis

转化手术后临床IV期胃癌的术后化疗:一项倾向性评分匹配分析

2025-08-270
OA
Robotic and laparoscopic gastrectomy for gastric cancer: comparative insights into perioperative performance and three-year survival outcomes

机器人和腹腔镜胃癌切除术: 对围手术期性能和三年生存结果的比较见解

2025-02-260
PRE
A striking elevation of CA19-9 after preoperative therapy negates prognostic benefit from radical surgery in resectable and borderline resectable pancreatic cancer
SURGERY
IF2.7
2024-10-016
PRE
Survival Impact of Inflammation-based Prognostic Scores in Metastatic or Unresectable Esophageal Cancer Treated With Pembrolizumab Plus Chemotherapy
2024-06-032
PRE
Significance of Comprehensive Analysis of Preoperative Sarcopenia Based on Muscle Mass, Muscle Strength, and Physical Function for the Prognosis of Patients with Esophageal Cancer
2023-11-214
PRE